Aperture Therapeutics
San Carlos
About Aperture Therapeutics
Aperture Therapeutics is a biotechnology company focused on the development of novel therapies for age-related neurodegenerative diseases. Utilizing a unique drug discovery platform, the company aims to harness the genetic diversity of patients to identify new disease pathways and drug targets. With operations based in a lab incubator, Aperture Therapeutics is in the pre-clinical stage, actively applying insights from neuroscience and immunology to advance its research. The company's approach emphasizes the importance of genetic diversity in the discovery process, aiming to lead to more effective treatments for neurodegeneration and neuroimmunology conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Pre-Seed (Feb 2024)
- Website: aperturetx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Life Science, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aperture-therapeutics-67465 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.